Table 2 HLA alleles of mobilized and non-mobilized donors
| Â | Donor | HLA A | HLA B | HLA C | CMV multimers analyzed | EBV multimers analyzed |
|---|---|---|---|---|---|---|
Mobilized | 1 | A*02:01 A*23:01 | B*41:02 B*51:01 | C*14:02 C*17:03 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL |
2 | A*02:01 A*03:01 | B*18:01 B*27:01 | C*02:02 C*12:03 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
3 | A*02:01 A*32:01 | B*13:02 B*40:02 | C*02:02 C*06:02 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
4 | A*02:01 | B*15:02 B*44:02 | C*03:03 C*05:01 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
5 | A*01:01 | B*35:01 B*49:01 | C*02:02 C*12:02 | A1/YSE, A1/VTE, B35/IPS | B35/HPV, B35/EPL, B35/YPL | |
6 | A*01:01 A*03:01 | B*07:02 | C*07:02 | A1/YSE, A1/VTE, B7/RPH, B7/TPR | B7/RPP | |
7 | A*02 A*24 | B*13 | C*06 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
8 | A*01:01 A*24:02 | B*08:01 B35*02 | C*04:01 C*07:01 | A1/YSE, A1/VTE, B8/ELK, B8/QIK | B8/RAK, B8/QAK | |
Non-mobilized | 9 | A*02 | B*07 B*35 | C*07 | A2/NLV, A2/VLE, B7/RPH, B7/TPR, B35/IPS, C7/CRV | A2/CLG, A2/GLC, A2/YVL, A2/FLY, B7/RPP, B35/HPV, B35/EPL, B35/YPL |
10 | A*01 A*02 | B*07 B*08 | nd | A1/YSE, A1/VTE, A2/NLV, A2/VLE, B7/RPH, B7/TPR, B8/ELK, B8/QIK | A2/CLG, A2/GLC, A2/YVL, A2/FLY, B7/RPP, B8/RAK, B8/QAK | |
11 | A*02 A*03 | B*27 B*62 | nd | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL, A2/FLY | |
12 | A*02 A*03 | B*15 B*35 | nd | A2/NLV, A2/VLE, B35/IPS | A2/CLG, A2/GLC, A2/YVL, A2/FLY, B35/HPV, B35/EPL, B35/YPL | |
13 | A*02 A*24 | B*44 B*51 | nd | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL, A2/FLY | |
14 | A*02 A*30 | B*18 B*39 | C*07 | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL | |
15 | A*02 A*26 | B*07 | C*06 C*07 | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL | |
16 | A*02 | B*07 B*08 | C*07 | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL |